The new version of ‘Quality Solutions for Inhaler Testing’ from Copley Scientific not only showcases the latest developments in inhaled product testing equipment but also provides practical guidance on achieving robust and reliable measurement and analysis.
A ‘go to’ resource for expert advice that is rooted in the latest regulatory guidance and pharmacopoeial monographs, the new brochure includes details of a cluster of novel products designed to deliver better in vitro in vivo relationships (IVIVRs) for all orally inhaled and nasal drug products (OINDPs).
Beginning with a review of the role of different organisations, expert groups and regulatory authorities, ‘Quality Solutions for Inhaler Testing’ presents the Copley range of inhaled product testing equipment within the context of how it can be used to meet research, development and QC requirements.
The new edition has been comprehensively revised, most noticeably to reflect an increased focus on achieving better IVIVRs. This is perceived by leading researchers as being critical for more effective inhaled product development.
Since the last edition of the brochure (2010), Copley have introduced a number of new tools for more representative testing, including: the Alberta Idealised Throat; breathing simulators for the testing of nebulisers and inhalers; and extensions to the abbreviated impactor measurement (AIM) range, which aids faster analysis.
Other important innovations include the new Plume Temperature tester, which is used in the assessment of the ‘Cold Freon’ effect, induced by propellant driven inhalers, and a new super capacity vacuum pump, specified for use at the highest test flow rates when testing DPI.